Pichardo-León N, Bringas-Sosa Y, Prada-Castillo CM, Kenanao-Kelebetse I

Language: Spanish
References: 15
Page: 917-925
PDF size: 488.08 Kb.

ABSTRACT

Background: mycetoma is a chronic and progressive inflammatory disease affecting the skin, soft tissues and bones; it is caused by bacteria and fungi. Clinically it manifests itself as nodules that tend to coalesce and form plaques with fistulous paths, which drain purulent or serosanguineous material with characteristic grains. Lower limbs are most affected.
Objetive: to show a patient with Madura foot, treated by Syme’s amputation.
Case report: a 42 years-old, black, male, HIV positive patient, with history of chronic lesions of the skin, soft tissues and metatarsals bones of the left foot, with more than eight years of evolution. Laboratory studies, radiological assessment and hysto-pathological examination were done and finally, mycetoma’s diagnosis by Madurella grisea was confirmed. According to the poor results obtained with other bone surgery and antifungal treatments; Syme’s amputation, as definitive management was performed.
Conclusions: this disease though rare in our environment, has worldwide prevalence; it should be considered within the differential diagnosis when chronic suppurative lesions are present in the lower limbs. In Madura foot, the best results are obtained with the amputation technique of the affected zone, such as the Syme’s procedure, which one minimizes the anatomical, functional and psycho-emotional sequel of the patient.

REFERENCES

1. Asial S, Chávez GV, Danze L, Abeldaño A. Micetoma por Acremonium. Dermatol Argent [Internet]. 2019 Oct-Dic [citado 03 Nov 2020];25(4):176-178. Disponible en: Disponible en: https://www.dermatolarg.org.ar/index.php/dermatolarg/article/view/1895

2. Hernández Del Pino SH, Aguilasocho Gaxiola MJ. Micetoma, reporte de un caso. Folia Dermatol Cubana [Internet]. 2017 [citado 03 Nov 2020];11(3):e59. Disponible en: Disponible en: http://www.revfdc.sld.cu/index.php/fdc/article/view/59/84

3. Ferrer Pérez A, Ramos Valdez JR, Marrero PA, Figueroa Valdés M. Eumicetoma como tumoración en la pierna. Acta médica del centro [Internet]. 2019 [citado 03 Nov 2020];13(4):[aprox. 8 p.]. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/medicadelcentro/mec-2019/mec194p.pdf

4. Espinosa S, Perales D, Ponce RM, Buitrón García R, Bonifaz A. Actinomicetoma en el embarazoReporte de un caso: ¿Qué hacer y cómo tratarlo? . Ginecol obstet Mex [Internet]. Mar 2017 [citado 03 Nov 2020];85(3):190-195. Disponible en: Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0300-90412017000300190

5. A Ali GA, Goravey W, Taj-Aldeen SJ, Petkar M, Al-Bozom I, Hadi HA. A case of mycetoma-like chromoblastomycosis in Qatar. IDCases [Internet]. 2020 [citado 03 Nov 2020];21:[aprox. 3 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283144/pdf/main.pdf

6. Ermutlu C, Akesen S. Levels of surgery does not affect the reamputation rates in patients with diabetic foot ulcers requiring amputation of the ankle or foot. Ann Med Res [Internet]. 2020 [citado 03 Nov 2020];27(6):1637-40. Disponible en: Disponible en: http://www.annalsmedres.org/articles/2020/volume27/issue6/1637-1640.pdf

7. Finkler ES, Marchwiany DA, Schiff AP, Pinzur MS. Long-term Outcomes Following Syme's Amputation. Foot Ankle Int [Internet]. 2017 [citado 03 Nov 2020];38(7):732-735. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28399654/ .

8. Saleme Cruz J, Arizola Cisneros L, Capdevila Leonori R, Haces García F. Desarticulación de tobillo (Syme) y amputación transtibial como tratamiento para las deficiencias del miembro pélvico. ¿Qué es mejor? Rev Mex Ortop Ped [Internet]. 2013 [citado 03 Nov 2020];15(2):[aprox. 6 p.]. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/opediatria/op-2013/op132d.pdf

9. Padilla Desgarennes MC, Caballero AM, Martínez Guerra E. Micetoma por Nocardia brasiliensis en región abdominal. Rev Cent Dermatol Pascua [Internet]. 2014 [citado 03 Nov 2020];23(1):17-21. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/derma/cd-2014/cd141d.pdf

10. Bienvenu AL, Picot S. Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers. Molecules [Internet]. 2020 [citado 03 Nov 2020];25(11):[aprox. 6 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321093/pdf/molecules-25-02594.pdf

11. Sigera LSM, Narangoda KUL, Dahanayake MY, Shabri ULF, Malkanthi MA, Somarathne V, et al. Mycetoma due to Madurella mycetomatis. IDCases [Internet]. 2020 [citado 03 Nov 2020];30:[aprox. 3 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283137/pdf/main.pdf

12. Al-Kathiri L, Al-Najjar T, Al-Asmaili A. Successful Treatment of Recalcitrant Actinomycetoma of Gluteal Area with Combined Medical Treatment and Surgical Excision with Graft Reconstruction. Oman Med J [Internet]. 2020 [citado 03 Nov 2020];35(2):[aprox. 5 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157440/ .

13. Schmidt I, Schmieder A. Necessity of secondary Syme amputation of the foot after severely destroyed hindfoot injury due to suicidal jump from height in a psychiatric patient: Case presentation and brief review of literature. Trauma Emerg Care [Internet]. 2017 [citado 03 Nov 2020];2(6):[aprox. 10 p.]. Disponible en: Disponible en: https://www.oatext.com/pdf/TEC-3-153.pdf

14. Braaksma R, Dijkstra PU, Geertzen JHB. Syme Amputation: A Systematic Review. Foot Ankle Int [Internet]. 2018 [citado 03 Nov 2020];39(3):284-291. Disponible en: Disponible en: https://journals.sagepub.com/doi/10.1177/1071100717745313

15. Poggio Cano D, García Elvira R. Amputaciones de la extremidad inferior en el paciente diabético. Mon Act [Internet]. 2018 [citado 03 Nov 2020];(10):57-65. Disponible en: Disponible en: https://fondoscience.com/mon-act-semcpt/num10-2018/fs1805010-amputaciones-de-la-extremidad-inferior-en-el-paciente-diabetico